AKBA icon

Akebia Therapeutics
AKBA

Overview Fund Activity

157 hedge funds and large institutions have $394M invested in Akebia Therapeutics in 2025 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 77 increasing their positions, 23 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
157
Holders Change
+13
Holders Change %
+9.03%
% of All Funds
2.11%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
32
Increased
77
Reduced
23
Closed
19
Calls
$2.2M
Puts
$1.51M
Net Calls
+$687K
Net Calls Change
+$1.22M

Top Buyers

1
BlackRock
BlackRock
New York
+$11.1M
2
MB
MPM BioImpact
Massachusetts
+$10.5M
3
Morgan Stanley
Morgan Stanley
New York
+$9.68M
4
NL
Nuveen LLC
North Carolina
+$8.58M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$7.01M

Top Sellers

1
GPP
Great Point Partners
Connecticut
-$10.9M
2
ACM
AIGH Capital Management
Maryland
-$5.62M
3
WP
Woodline Partners
California
-$5.4M
4
Citadel Advisors
Citadel Advisors
Florida
-$4.84M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$4.5M
Name Holding Trade Value Shares
Change 		Shares
Change %
BT
176
Banque Transatlantique
France
– -$3.99K -2,250 Closed
Northwestern Mutual Wealth Management
177
Northwestern Mutual Wealth Management
Wisconsin
– -$10 -5 Closed
4 5 6 7
8